| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| R&D Expense | $1.4M | — | -0.7% |
| SG&A Expense | $892K | — | +28.5% |
| Operating Income | -$2.3M | — | -8.9% |
| Pre-tax Income | -$2.3M | — | -8.9% |
| Income Tax | $13 | — | +0.0% |
| Net Income | -$2.3M | — | -8.9% |
| EPS (Basic) | -$0.05 | — | +16.7% |
| EPS (Diluted) | -$0.05 | — | +16.7% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Current Assets | $2.2M | +28.6% | +128.5% |
| Total Assets | $3.7M | +15.1% | +49.6% |
| Current Liabilities | $8.9M | -34.1% | +108.8% |
| Total Liabilities | $8.9M | -34.1% | +108.8% |
| Stockholders' Equity | -$5.3M | +49.2% | -187.8% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$6.7M | — | -1337.4% |
| Financing Cash Flow | $7.2M | — | — |